U.S. Weightlifting Athlete Emily Malinowski Accepts Sanction for Anti-Doping Rule Violation
28th August 2018
USADA announced today that Emily Malinowski, of Elmwood Park, Ill., an athlete in the sport of weightlifting, has tested positive for a prohibited substance and accepted a four-year sanction for her violation. This sanction was subsequently reduced by three-months at the discretion of USADA and the World Anti-Doping Agency (WADA), and in accordance with the rules, based on Malinowski’s prompt admission of the violation.
Malinowski, 29, tested positive for the presence of an anabolic agent and/or its metabolites as the result of an in-competition urine sample she provided on December 10, 2017, at the American Open Series Finals. Her urine sample was analyzed using a specialized test that differentiates between anabolic-androgenic steroids naturally produced by the body and prohibited anabolic agents of external origin. Anabolic agents have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors. The use of anabolic agents is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the WADA Prohibited List.
Malinowski’s 45-month period of ineligibility began on January 29, 2018, the date she accepted a provisional suspension. In addition, Malinowski has been disqualified from competitive results obtained on and subsequent to December 10, 2017, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.